ECL1i
ECL1i is an allosteric, selective CCR2 inhibitor. ECL1i specifically inhibits CCL2-/CCR2-mediated chemotaxis. ECL1i interferes with CCR2-positive cell recruitment and attenuates disease progression in experimental autoimmune encephalomyelitis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1417312-35-6
- Fòrmula: C36H60N8O9S
- Peso molecular:780.97
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
|
CCR2 |
Chemical Information
-
No. CAS 1417312-35-6
-
Peso molecular 780.97
-
Fòrmula C36H60N8O9S
-
Sequence
d(Leu-Gly-Thr-Phe-Leu-Lys-Cys)
-
Sequence Shortening
d(LGTFLKC)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)